AUDIT

审计

基本信息

  • 批准号:
    7515876
  • 负责人:
  • 金额:
    $ 10.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-14 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

2.8.1.6 Internal Audits The NCCTG Quality Control Unit conducts rigorous internal audits to verify internal compliance with SOPs, proper use of automated systems, and internal consistency. The goal of these audits is to further assure the quality of the study data, to ensure the delivery of accurate, timely and reliable trial results, and to provide educational support to the staff. Concurrently with these audits, the electronic applications are reviewed to ensure that systems are being used correctly, ensure the systems are user friendly and functioning properly, and identify any improvements necessary to increase the overall efficiency and productivity of the unit. The audits are conducted at least annually and last one to two days. Studies are selected randomly with at least 2-5 cases being chosen for each Quality Control Specialist. An audit check list is used to ensure a comprehensive review of charts. Eligibility, objective response, dosing, adverse event reporting, and timeliness of editing are reviewed. The second objective of the audit, ensuring systems are functioning and being used correctly, is accomplished by verifying that the proper edits were identified, that case evaluation reviews were triggered when appropriate, and that the materials tracking system was correctly implemented. Upon completion of the audit, each Quality Control Specialist receives a written audit report and is asked to address and clarify any items of concern within thirty days of receipt. The quality control specialist supervisor reviews all responses for acceptability and follow-up with the quality control specialist on training and education needs. 2.8.1.7 NCCTG External Audit All NCCTG memberships are audited at least once every 3 years to further ensure the delivery of accurate and reliable clinical trials data and results, to verify the accuracy of submitted data, to monitor compliance to the study protocol, to verify adherence to regulatory requirements for the protection of human subjects and the handling of investigational agents, and to provide educational support to the NCCTG memberships. The results of these audits are reviewed by the NCCTG Audit Committee who oversees the audit process for NCCTG and reports directly to the NCCTG Executive Committee. The results of individual chart review are summarized by category (informed consent, eligibility, treatment, disease outcome, toxicity, and general data quality) and severity of discrepancy (lesser or major). The percent of major deficiencies has remained low with the median percent of major deficiencies below 5% (2001=3%, 2002=4%, 2003=3%, 2004=1%, 2005=2%). When deficiencies are identified that potentially affect submitted data, a memo is sent to both the primary CRA at the site and the quality control specialist communicating the data discrepancy. The quality control specialist is then responsible for tracking the query until resolution in the database. An audit report is included as Appendix XI.
2.8.1.6内部审计 NCCTG质量控制部门进行严格的内部审核,以验证内部是否符合标准操作规程; 自动化系统的正确使用,以及内部一致性。这些审计的目标是进一步确保 研究数据的质量,以确保交付准确、及时和可靠的试验结果,并提供 对员工的教育支持。与这些审计同时,电子申请也会被审查,以 确保正确使用系统,确保系统对用户友好并正常运行, 并确定任何必要的改进,以提高单位的整体效率和生产率。 审计至少每年进行一次,持续一到两天。研究是随机选择的,在 每个质量控制专家至少选择2-5个案例。审计核对表用于确保 全面回顾图表。资格、客观反应、剂量、不良事件报告,以及 对编辑的及时性进行了回顾。审计的第二个目标是确保系统正常运行和 正确使用,是通过验证是否识别了适当的编辑、案例评估 在适当的时候触发了审查,并确保正确实施了材料跟踪系统。 完成审核后,每位质量控制专家将收到一份书面审核报告,并被要求 在收到邮件后30天内解决并澄清任何关注的事项。质量控制专家监督员 与培训和教育方面的质量控制专家一起审查所有答复的可接受性和后续行动 需要。 2.8.1.7 NCCTG外部审计 所有NCCTG会员至少每3年审核一次,以进一步确保交付准确和 可靠的临床试验数据和结果,以验证提交的数据的准确性,监测对 研究方案,以验证遵守保护人类受试者和 处理调查人员,并为NCCTG成员提供教育支持。这个 这些审计的结果由NCCTG审计委员会审查,该委员会监督以下审计过程 NCCTG并直接向NCCTG执行委员会报告。个别图表评审结果如下 按类别(知情同意、资格、治疗、疾病结局、毒性和一般数据)汇总 质量)和差异的严重程度(较小或较大)。主要缺陷的比例仍然很低, 低于5%的主要缺陷的中位数百分比(2001年=3%,2002年=4%,2003年=3%,2004年=1%,2005年=2%)。 当发现可能影响已提交数据的缺陷时,将向两个主要CRA发送一份备忘录 在现场和质量控制专家沟通数据差异。质量控制专家 然后负责跟踪查询,直到数据库中的解析。一份审计报告包括在 附录XI。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES L LOPRINZI其他文献

CHARLES L LOPRINZI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES L LOPRINZI', 18)}}的其他基金

Survivorship research established investigator award
生存研究设立研究者奖
  • 批准号:
    7826598
  • 财政年份:
    2008
  • 资助金额:
    $ 10.47万
  • 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
  • 批准号:
    7466151
  • 财政年份:
    2008
  • 资助金额:
    $ 10.47万
  • 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
  • 批准号:
    8078080
  • 财政年份:
    2008
  • 资助金额:
    $ 10.47万
  • 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
  • 批准号:
    8282597
  • 财政年份:
    2008
  • 资助金额:
    $ 10.47万
  • 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
  • 批准号:
    7629717
  • 财政年份:
    2008
  • 资助金额:
    $ 10.47万
  • 项目类别:
SUPPLEMENT
补充
  • 批准号:
    7528977
  • 财政年份:
    2007
  • 资助金额:
    $ 10.47万
  • 项目类别:
STATISTICAL SUPPORT UNIT
统计支持单位
  • 批准号:
    7515853
  • 财政年份:
    2007
  • 资助金额:
    $ 10.47万
  • 项目类别:
OPERATIONS UNIT
营运单位
  • 批准号:
    7515871
  • 财政年份:
    2007
  • 资助金额:
    $ 10.47万
  • 项目类别:
ADMINISTRATION
行政
  • 批准号:
    7515849
  • 财政年份:
    2007
  • 资助金额:
    $ 10.47万
  • 项目类别:
CAPITATION
按人头付费
  • 批准号:
    7515885
  • 财政年份:
    2007
  • 资助金额:
    $ 10.47万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 10.47万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了